576
E. Błocka et al. / Tetrahedron: Asymmetry 21 (2010) 571–577
in reciprocal centimeters (cmꢀ1) and are measured as a HCB mull.
GC was performed on a Perkin–Elmer AutoSystem XL chromato-
graph using b-Dex 325 capillary column (30 m, 0.25 mm) or on
Shimadzu GC-14A using Zebron ZB-5 capillary column. HPLC
analyses were performed on a Shimadzu LC-10AT chromatograph
using Chiralcel OD-H column (250 ꢁ 4.6 mm). Crystals suitable
for the diffraction experiments were obtained by the vapor
diffusion method from an ethanol solution. The X-ray data for
all reported structures were collected at 293(2) K with an Oxford
4.3.2. 4-Bromo-2-((2S,4S,5R)-3,4-dimethyl-5-phenyl-
oxazolidyn-2-yl)phenol 2
4-Bromo-2-hydroxybenzaldehyde as a substrate. White solid
(77%). Purified by crystallization using ethanol at 4 °C (after 4 h).
Mp 182–185 °C,
½
a 2D0
ꢂ
¼ ꢀ79:2 (c 0.096, CH3OH). 1H NMR
(200 MHz, CDCl3): d 0.84 (d, J = 6.4 Hz, 3H, CH3), 2.38 (s, 3H,
CH3), 3.10 (qd, J = 2.2 Hz, J = 6.4 Hz, 1H, CH), 4.86 (s, 1H, CH), 5.26
(d, J = 8.6 Hz, 1H, CH), 6.83 (d, J = 8.6 Hz, 1H, CHAr), 7.34 (m, 7H,
CHAr), 11.51 (br s, 1H, OH). 13C NMR (50.3 MHz, CDCl3): d 15.67
(CH3), 35.87 (CH3), 63.53 (CH), 81.56 (CH), 98.22 (CH), 110.61
(CAr), 118.98 (CHAr), 121.01 (CAr), 126.93 (3 ꢁ CHAr), 127.99 (CHAr),
128.21 (CHAr), 133.53 (CHAr), 133.63 (CHAr), 137.92 (CAr), 157.45
(CAr). IR (HCB mull): 702.5, 716.0, 760.7, 1083.9, 1269.1, 1337.0,
1470.7, 1482.3, 2893.7, 2986.0. Anal. Calcd for C17H18BrNO2: C,
58.63; H, 5.21; Br, 22.95; N, 4.02; O, 9.19. Found: C, 58.61; H,
5.27; N, 4.22.
Sapphire CCD diffractometer using Mo Ka radiation k = 0.71073 Å
and
x
ꢀ 2h method. The numerical absorption correction was ap-
plied with CrysAlis171 package of programs, Oxford Diffraction,
2000.22 Structures were solved by direct methods and refined
with the full-matrix least-squares method on F2 with the use of
SHELX-97 program package.23 The hydrogen atoms have been lo-
cated from the difference electron density maps and constrained
during refinement. The absolute configuration for 2 was deter-
mined by the Flack method.17 The Flack parameter for 1, 3, 5,
and 6 was inconclusive, so the absolute configuration of C2 was
determined relative to the configuration of (1R,2S)-ephedrine
used as a substrate in the synthesis of the oxazolidines. The struc-
tural data have been deposited with Cambridge Crystallographic
Data Centre, the CCDC numbers 762318–762322 for 2, 3, 5, 6
and 1, respectively.
4.3.3. 2-((2S,4S,5R)-3,4-Dimethyl-5-phenyl-oxazolidyn-2-yl)-6-
methyl-phenol 3
2-Hydroxy-3-methylbenzaldehyde as a substrate. White solid
(50%). Purified by crystallization using ethanol at 4 °C (after 4 h).
Mp 125–127 °C,
½
a 2D0
ꢂ
¼ þ8:16 (c 0.56, CH3OH). 1H NMR
(300 MHz, CDCl3): d 0.83 (d, J = 6.6 Hz, 3H, CH3), 2.29 (s, 3H,
CH3), 2.39 (s, 3H, CH3), 3.09 (qd, J = 2.1 Hz, J = 6.6 Hz, 1H, CH),
4.91 (s, 1H, CH), 5.23 (d, J = 8.7 Hz, 1H, CH), 6.77 (t, J = 7.5 Hz, 1H,
CH), 7.06 (dd, J = 1.5 Hz, J = 7.7 Hz, 1H, CHAr), 7.17 (dd, J = 1.5 Hz,
J = 7.7 Hz, 1H, CHAr), 7.24–7.40 (m, 5H, CHAr), 11.54 (br s, 1H,
OH). 13C NMR (50.3 MHz, CDCl3): d 15.79 (CH3), 31.20 (CH3),
35.89 (CH3), 59.50 (CH), 81.40 (CH), 99.19 (CH), 118.19 (CAr),
118.56 (CHAr), 125.69 (CAr), 127.13 (2ꢁCHAr), 127.84 (CHAr),
128.13 (2 ꢁ CHAr), 128.64 (CHAr), 132.03 (CHAr), 138.23 (CAr),
156.35 (CAr). IR (HCB mull): 708.5, 753.7, 1262.9, 1382.3, 1454.7,
1471.9, 2917.0, 2969.4. Anal. Calcd for C18H21NO2: C, 76.29; H,
7.47; N, 4.94; O, 11.29. Found: C, 76.19; H, 7.27; N, 5.02.
4.2. Materials
TLC was performed on silica gel PolygramÒ Sil G/UV254 (0.2 mm).
Regular column chromatography was carried out using Silica Gel 60
(0.06–0.2 mm). All solvents were purchased from POCh Gliwice,
Poland. Toluene was distilled from sodium prior to use. Diethylzinc,
(ꢀ)-ephedrine, and aldehydes were purchased from Sigma–Aldrich
or Fluka. 3,5-Di-tert-butyl-2-hydroxybenzaldehyde, 3-tert-butyl-5-
methyl-2-hydroxybenzaldehyde, 2-hydroxy-3-methylbenzaldehyde,
and 2-hydroxy-3-isopropylbenzaldehyde were obtained according
to the literature procedures.24,25
4.3.4. 2-((2S,4S,5R)-3,4-Dimethyl-5-phenyl-oxazolidin-2-yl)-6-
isopropyl-phenol 4
2-Hydroxy-3-isopropylbenzaldehyde as a substrate. White solid
(73%). Purified by crystallization using ethanol at 4 °C (4 h). Mp
4.3. Preparation of oxazolidines
105–106 °C, ½a 2D0
ꢂ
¼ þ5:0 (c 2.09, CH3OH). 1H NMR (300 MHz,
CDCl3): d 0.84 (d, J = 6.3 Hz, 3H, CH3), 1.27 (d, J = 6.3 Hz, 3H, CH3-
iPr), 1.29 (d, J = 6.0 Hz, 3H, CH3-iPr), 1.57 (br s, 1H, OH), 2.38 (s,
3H, CH3), 3.08 (qd, J = 8.7 Hz, J = 6.6 Hz, 1H, CH), 3.39 (qt,
J = 6.9 Hz, 1H, CH), 4.92 (s, 1H, CH), 5.27 (d, J = 8.7 Hz, 1H, CH),
6.84 (t, J = 7.8 Hz, 1H, CHAr), 7.06 (dd, J = 1.8 Hz, J = 7.5 Hz, 1H,
CHAr), 7.23–7.41 (m, 6H, CHAr), 11.62 (br s, 1H, OH). 13C NMR
(50.3 MHz, CDCl3): d 15.65 (CH3), 22.54 (CH3), 26.52 (CH), 35.73
(CH3), 63.48 (CH), 81.36 (CH), 99.38 (CHAr), 118.30 (CAr), 118.69
(CHAr), 127.11 (2ꢁCHAr), 127.33 (CHAr), 127.76 (CHAr), 128.07
(2 ꢁ CHAr), 128.45 (CHAr), 135.98 (CAr), 138.33 (CAr), 155.48 (CAr).
IR (HCB mull): 713.5, 753.7, 827.8, 1249.8, 1270.1, 1454.2,
1467.6, 2858.3, 2968.3. Anal. Calcd for C20H25NO2: C, 77.14; H,
8.09; N, 4.50; O, 10.28. Found: C, 77.08; H, 7.94; N, 4.35.
A 50-ml round-bottomed flask equipped with a magnetic stir-
ring bar was filled with 3.05 mmol (0.5 g) of (1R,2S)-ephedrine,
2,77 mmol of appropriate aldehyde, and 30 ml of anhydrous etha-
nol. The reaction mixture was stirred for 24 h at room temperature
and then it was transferred to crystallizer. The precipitate was
drained, washed by ethanol (10 ml), and dried in the air. Yields
and physical properties are presented below.
4.3.1. ((2S,4S,5R)-3,4-Dimethyl-5-phenyl-oxazolidyn-2-yl)
phenol 1
2-Hydroxybenzaldehyde as a substrate. White solid (56%).
Purified by crystallization using ethanol at 4 °C (after 4 h). Mp
119–121 °C (lit.13 112–114 °C), ½a 2D0
¼ ꢀ32:6 (c 0.47, CH3OH)
ꢂ
(lit.13
½
a 2D0
ꢂ
¼ ꢀ32:3 (c 0.62, CHCl3)).1H NMR (300 MHz, CDCl3): d
4.3.5. 2-tert-Butyl-6-((2S,4S,5R)-3,4-dimethyl-5-phenyl-
oxazolidyn-2-yl)-4-methyl-phenol 5
0.83 (d, J = 6.6 Hz, 3H, CH3), 2.38 (s, 3H, CH3), 3.09 (qd,
J = 2.2 Hz, J = 6.5 Hz, 1H, CH), 4.92 (s, 1H, CH), 5.26 (d, J = 8.7 Hz,
1H, CH), 6.86 (td, J = 1.2 Hz, J = 7.5 Hz, 1H, CHAr), 6.90 (dd,
J = 0.9 Hz, J = 8.4 Hz, 1H, CHAr), 7.20–7.399 (m, 7H, CHAr), 11.38
(br s, 1H, OH). 13C NMR (75.5 MHz, CDCl3): d 15.71 (CH3), 35.86
(CH3), 63.59 (CH), 81.46 (CH), 99.08 (CH), 117.00 (CHAr), 119.08
(CHAr), 119.08 (CAr), 127.05 (2 ꢁ CHAr), 127.88 (CHAr), 128.16
(2 ꢁ CHAr), 130.92 (CHAr), 131.05 (CHAr), 138.26 (CAr), 158.23
(CAr). IR (HCB mull): 701.9, 715.6, 764.4, 1265.1, 1336.0, 1455.9,
1481.9, 2898.0, 2984.0. Anal. Calcd for C17H19NO2: C, 75.81; H,
7.11; N, 5.20; O, 11.88. Found: C, 75.51; H, 7.34; N, 5.43.
3-tert-Butyl-2-hydroxy-5-methylbenzaldehyde as a substrate.
White solid (58%). Purified by crystallization using ethanol at
4 °C (24 h). Mp 122–125 °C, ½a D20
ꢂ
¼ ꢀ7:2 (c 0.40, CH3OH). 1H NMR
(300 MHz, CDCl3): d 0.83 (d, J = 6.4 Hz, 3H, CH3), 1.46 (s, 9H,
3 ꢁ CH3, t-Bu), 2.27 (s, 3H, CH3), 2.36 (s, 3H, CH3), 3.07 (qd,
J = 2.0 Hz, J = 6.4 Hz, 1H, CH), 4.87 (s, 1H, CH), 5.24 (d, J = 8.8 Hz,
1H, CH), 6.87 (d, J = 2.2 Hz,1H, CHAr), 7.11 (d, J = 2.2 Hz, 1H, CHAr),
7.23–7.42 (m, 5H, CHAr), 11.54 (br s, 1H, OH). 13C NMR
(75.5 MHz, CDCl3): d 15.50 (CH3), 20.66 (CH3), 29.47 (3 ꢁ CH3),
35.57 (CH3), 63.64 (CH), 81.38 (CH), 99.90 (CH), 118.52 (CAr),